The Center for Molecular Oncology at NYU Langone Health's Perlmutter Cancer Center will soon launch a new protocol for patients diagnosed with early-stage and advanced cancers, developing new ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Caris Life Sciences aims to standardize MET immunohistochemistry testing for non-squamous non-small cell lung cancer to enhance molecular insights and treatment personalization. MET protein expression ...
Evaluating lung cancer clinical characteristics and tumor subtypes using cell-free DNA fragmentomes. A retrospective study of induction immunochemotherapy followed by definitive chemoradiotherapy and ...
A machine learning lung cancer risk prediction model outperformed logistic regression, supporting improved risk assessment and more efficient radiology based lung cancer screening.
Hosted on MSN
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer
Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung cancers are non-small cell lung cancers, in which tumor cells are larger and ...
UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback